Enzon Pharmaceuticals 8-K Filing: Ninth Amendment to Section 382 Rights Agreement Announced March 2026
Enzon Pharmaceuticals Announces Extension of Exchange Offer ...
Sign in to continue:
Enzon Pharmaceuticals Announces Extension of Exchange Offer ...
CNS Pharmaceuticals Strategic Pivot: Key Investor Updates ...
Greenidge Generation Holdings Inc. Exchange Offer Detailed R...
Regency Centers, L.P. Form 8-K Filing - Key Investor Update ...
374Water Secures 5-Year Waste Destruction Services Agreement...
Hashdex Announces Major Leadership Restructuring to Drive Gl...
Autoliv Announces Appointment of New CFO: Key Details for In...
Bunker Hill Mining Corp. Announces Key Finance Team Changes,...
Lineage Cell Therapeutics, Inc. Announces New At-The-Market ...
Kodiak Gas Services Announces \$750 Million Senior Unsecured...